世界のバンコマイシン耐性腸球菌フェシウム治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5719 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、バンコマイシン耐性腸球菌フェシウム治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダプトマイシン、リネゾリド、キヌプリスチン/ダルホプリスチン、アンピシリン、クロラムフェニコール、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・バンコマイシン耐性腸球菌フェシウム治療薬の市場動向 ・企業の競争状況、市場シェア ・バンコマイシン耐性腸球菌フェシウム治療薬の種類別市場規模と予測2016-2027（ダプトマイシン、リネゾリド、キヌプリスチン/ダルホプリスチン、アンピシリン、クロラムフェニコール、その他） ・バンコマイシン耐性腸球菌フェシウム治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・バンコマイシン耐性腸球菌フェシウム治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・バンコマイシン耐性腸球菌フェシウム治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・バンコマイシン耐性腸球菌フェシウム治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バンコマイシン耐性腸球菌フェシウム治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・バンコマイシン耐性腸球菌フェシウム治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alchemia Limited、Alvogen、Aphios Corporation、Cellceutix Corporation、Enanta Pharmaceuticals、Helix BioMedix、LegoChem Biosciences、Lytix Biopharma、MGB Biopharma Limited、Microbiotix） ・結論

Market Analysis and Insights: Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market
The global Drugs for Vancomycin-Resistant Enterococcus Faecium market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs for Vancomycin-Resistant Enterococcus Faecium market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs for Vancomycin-Resistant Enterococcus Faecium market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs for Vancomycin-Resistant Enterococcus Faecium market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs for Vancomycin-Resistant Enterococcus Faecium market.

Global Drugs for Vancomycin-Resistant Enterococcus Faecium Scope and Market Size
Drugs for Vancomycin-Resistant Enterococcus Faecium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Vancomycin-Resistant Enterococcus Faecium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Daptomycin
Linezolid
Quinupristin/dalfopristin
Ampicillin
Chloramphenicol
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin/dalfopristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Market by Application
1.3.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Perspective (2016-2027)
2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Growth Trends by Regions
2.2.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Historic Market Share by Regions (2016-2021)
2.2.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Forecasted Market Size by Regions (2022-2027)
2.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Dynamic
2.3.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Trends
2.3.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Drivers
2.3.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Challenges
2.3.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players by Revenue
3.1.1 Global Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players by Revenue (2016-2021)
3.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Players (2016-2021)
3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue
3.4 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Concentration Ratio
3.4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in 2020
3.5 Drugs for Vancomycin-Resistant Enterococcus Faecium Key Players Head office and Area Served
3.6 Key Players Drugs for Vancomycin-Resistant Enterococcus Faecium Product Solution and Service
3.7 Date of Enter into Drugs for Vancomycin-Resistant Enterococcus Faecium Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Vancomycin-Resistant Enterococcus Faecium Breakdown Data by Type
4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Historic Market Size by Type (2016-2021)
4.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecasted Market Size by Type (2022-2027)

5 Drugs for Vancomycin-Resistant Enterococcus Faecium Breakdown Data by Application
5.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Historic Market Size by Application (2016-2021)
5.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (2016-2027)
6.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type
6.2.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021)
6.2.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027)
6.2.3 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2027)
6.3 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application
6.3.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021)
6.3.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027)
6.3.3 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2027)
6.4 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country
6.4.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021)
6.4.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (2016-2027)
7.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type
7.2.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021)
7.2.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027)
7.2.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2027)
7.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application
7.3.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021)
7.3.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027)
7.3.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2027)
7.4 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country
7.4.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021)
7.4.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (2016-2027)
8.2 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type
8.2.1 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2027)
8.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application
8.3.1 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2027)
8.4 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region
8.4.1 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (2016-2027)
9.2 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type
9.2.1 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021)
9.2.2 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027)
9.2.3 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2027)
9.3 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application
9.3.1 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021)
9.3.2 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027)
9.3.3 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2027)
9.4 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country
9.4.1 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021)
9.4.2 Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (2016-2027)
10.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type
10.2.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2027)
10.3 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application
10.3.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2027)
10.4 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country
10.4.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alchemia Limited
11.1.1 Alchemia Limited Company Details
11.1.2 Alchemia Limited Business Overview
11.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.1.4 Alchemia Limited Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.1.5 Alchemia Limited Recent Development
11.2 Alvogen
11.2.1 Alvogen Company Details
11.2.2 Alvogen Business Overview
11.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.2.4 Alvogen Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.2.5 Alvogen Recent Development
11.3 Aphios Corporation
11.3.1 Aphios Corporation Company Details
11.3.2 Aphios Corporation Business Overview
11.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.3.4 Aphios Corporation Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.3.5 Aphios Corporation Recent Development
11.4 Cellceutix Corporation
11.4.1 Cellceutix Corporation Company Details
11.4.2 Cellceutix Corporation Business Overview
11.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.4.4 Cellceutix Corporation Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.4.5 Cellceutix Corporation Recent Development
11.5 Enanta Pharmaceuticals
11.5.1 Enanta Pharmaceuticals Company Details
11.5.2 Enanta Pharmaceuticals Business Overview
11.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.5.4 Enanta Pharmaceuticals Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.5.5 Enanta Pharmaceuticals Recent Development
11.6 Helix BioMedix
11.6.1 Helix BioMedix Company Details
11.6.2 Helix BioMedix Business Overview
11.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.6.4 Helix BioMedix Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.6.5 Helix BioMedix Recent Development
11.7 LegoChem Biosciences
11.7.1 LegoChem Biosciences Company Details
11.7.2 LegoChem Biosciences Business Overview
11.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.7.4 LegoChem Biosciences Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.7.5 LegoChem Biosciences Recent Development
11.8 Lytix Biopharma
11.8.1 Lytix Biopharma Company Details
11.8.2 Lytix Biopharma Business Overview
11.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.8.4 Lytix Biopharma Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.8.5 Lytix Biopharma Recent Development
11.9 MGB Biopharma Limited
11.9.1 MGB Biopharma Limited Company Details
11.9.2 MGB Biopharma Limited Business Overview
11.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.9.4 MGB Biopharma Limited Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.9.5 MGB Biopharma Limited Recent Development
11.10 Microbiotix
11.10.1 Microbiotix Company Details
11.10.2 Microbiotix Business Overview
11.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Introduction
11.10.4 Microbiotix Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
11.10.5 Microbiotix Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Daptomycin
Table 3. Key Players of Linezolid
Table 4. Key Players of Quinupristin/dalfopristin
Table 5. Key Players of Ampicillin
Table 6. Key Players of Chloramphenicol
Table 7. Key Players of Others
Table 8. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Regions (2016-2021)
Table 12. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Regions (2022-2027)
Table 14. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Trends
Table 15. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Drivers
Table 16. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Challenges
Table 17. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Restraints
Table 18. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Players (2016-2021)
Table 20. Global Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium as of 2020)
Table 21. Ranking of Global Top Drugs for Vancomycin-Resistant Enterococcus Faecium Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Drugs for Vancomycin-Resistant Enterococcus Faecium Product Solution and Service
Table 25. Date of Enter into Drugs for Vancomycin-Resistant Enterococcus Faecium Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Type (2016-2021)
Table 29. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Application (2016-2021)
Table 33. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2022-2027) & (US$ Million)
Table 65. Alchemia Limited Company Details
Table 66. Alchemia Limited Business Overview
Table 67. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 68. Alchemia Limited Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 69. Alchemia Limited Recent Development
Table 70. Alvogen Company Details
Table 71. Alvogen Business Overview
Table 72. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 73. Alvogen Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 74. Alvogen Recent Development
Table 75. Aphios Corporation Company Details
Table 76. Aphios Corporation Business Overview
Table 77. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 78. Aphios Corporation Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 79. Aphios Corporation Recent Development
Table 80. Cellceutix Corporation Company Details
Table 81. Cellceutix Corporation Business Overview
Table 82. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 83. Cellceutix Corporation Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 84. Cellceutix Corporation Recent Development
Table 85. Enanta Pharmaceuticals Company Details
Table 86. Enanta Pharmaceuticals Business Overview
Table 87. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 88. Enanta Pharmaceuticals Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 89. Enanta Pharmaceuticals Recent Development
Table 90. Helix BioMedix Company Details
Table 91. Helix BioMedix Business Overview
Table 92. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 93. Helix BioMedix Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 94. Helix BioMedix Recent Development
Table 95. LegoChem Biosciences Company Details
Table 96. LegoChem Biosciences Business Overview
Table 97. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 98. LegoChem Biosciences Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 99. LegoChem Biosciences Recent Development
Table 100. Lytix Biopharma Company Details
Table 101. Lytix Biopharma Business Overview
Table 102. Lytix Biopharma Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 103. Lytix Biopharma Recent Development
Table 104. MGB Biopharma Limited Company Details
Table 105. MGB Biopharma Limited Business Overview
Table 106. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 107. MGB Biopharma Limited Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 108. MGB Biopharma Limited Recent Development
Table 109. Microbiotix Company Details
Table 110. Microbiotix Business Overview
Table 111. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product
Table 112. Microbiotix Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021) & (US$ Million)
Table 113. Microbiotix Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type: 2020 VS 2027
Figure 2. Daptomycin Features
Figure 3. Linezolid Features
Figure 4. Quinupristin/dalfopristin Features
Figure 5. Ampicillin Features
Figure 6. Chloramphenicol Features
Figure 7. Others Features
Figure 8. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Drugs for Vancomycin-Resistant Enterococcus Faecium Report Years Considered
Figure 13. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Regions: 2020 VS 2027
Figure 16. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Regions (2022-2027)
Figure 17. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Players in 2020
Figure 18. Global Top Drugs for Vancomycin-Resistant Enterococcus Faecium Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Vancomycin-Resistant Enterococcus Faecium as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue in 2020
Figure 20. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Type (2016-2021)
Figure 21. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Type (2022-2027)
Figure 22. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type (2016-2027)
Figure 24. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application (2016-2027)
Figure 25. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2016-2027)
Figure 26. United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type (2016-2027)
Figure 30. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application (2016-2027)
Figure 31. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2016-2027)
Figure 32. Germany Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Region (2016-2027)
Figure 42. China Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type (2016-2027)
Figure 50. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application (2016-2027)
Figure 51. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2016-2027)
Figure 52. Mexico Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2016-2027)
Figure 58. Turkey Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Alchemia Limited Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 62. Alvogen Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 63. Aphios Corporation Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 64. Cellceutix Corporation Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 65. Enanta Pharmaceuticals Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 66. Helix BioMedix Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 67. LegoChem Biosciences Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 68. Lytix Biopharma Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 69. MGB Biopharma Limited Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 70. Microbiotix Revenue Growth Rate in Drugs for Vancomycin-Resistant Enterococcus Faecium Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---